Barclays analyst issues OVERWEIGHT recommendation for BCS on September 8, 2026 07:32AM ET. The previous analyst recommendation was Neutral.BCS was trading at $27 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 17 - Buy, 7 - Hold, 1 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious...
Citigroup analyst issues MARKET OUTPERFORM recommendation for DKNG on September 8, 2026 08:22AM ET. The previous...
Key Points - Health minister warns of patient mistrust affecting NHS research due to data sharing...
Key Points - Representative David J. Taylor reports six new congressional stock trades - Microsoft's cash...
Key Points - Super Micro has gained 35% in 2026 - Super Micro outpaced the S&P...
from Arete Research issued a price target of $152.00 for SE on 2026-09-07 21:52:32.The adjusted price target was set to $152.00.At the time of the announcement, SE was trading at...
from Arete Research issued a price target of $30.00 for JD on 2026-09-07 21:50:28.The adjusted price target was set to $30.00.At the time of the announcement, JD was trading at...
from UBS issued a price target of $13.00 for CLF on 2026-09-07 12:05:58.The adjusted price target was set to $13.00.At the time of the announcement, CLF was trading at $12.5.The...
from Morgan Stanley issued a price target of $68.10 for BTI on 2026-09-07 11:21:22.The adjusted price target was set to $68.10.At the time of the announcement, BTI was trading at...
Robin Zhu from Bernstein issued a price target of $165.00 for BABA on 2026-09-07 06:10:00.The adjusted price target was set to $165.00.At the time of the announcement, BABA was trading...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Micron Technology's stock has seen a notable decline, falling almost 20% from its 52-week high, signaling potential volatility in the semiconductor market. The significant drop in trading volumes suggests a...
The U.S. National Transportation Safety Board (NTSB) is scheduled to hold a media briefing at 4 p.m. EDT (2000 GMT) on Monday to discuss the latest developments regarding the tragic...
In recent trading activity, Representative David J. Taylor, a Republican from Ohio, has made headlines with his reported transactions involving six congressional stock trades. Among these trades, Taylor has divested...
In the dynamic realm of technology and innovation, Apple Inc. is gearing up to make waves as it prepares for the anticipated unveiling of its first foldable iPhone later this...
In a dynamic second quarter of 2026, Tesla achieved a remarkable milestone by delivering a record number of vehicles, a feat that typically signifies success in the automotive sector. Nevertheless,...
